blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1718624

EP1718624 - BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATING AGENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.01.2010
Database last updated on 25.09.2024
Most recent event   Tooltip14.09.2012Lapse of the patent in a contracting state
New state(s): HU		published on 17.10.2012  [2012/42]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2009/13]
Former [2006/45]For all designated states
AstraZeneca AB
S-151 85 Södertälje / SE
Inventor(s)01 / JOHNSTONE, Craig, AstraZeneca R & D Alderley
Alderley Park, Macclesfield
Cheshire SK10 4TG / GB
02 / MCKERRECHER, Darren, AstraZeneca R & D Alderley
Alderley Park, Macclesfield
Cheshire SK10 4TG / GB
03 / PIKE, Kurt, Gordon, AstraZeneca R & D Alderley
Alderley Park, Macclesfield
Cheshire SK10 4TG / GB
 [2006/45]
Application number, filing date05708360.215.02.2005
[2006/45]
WO2005GB00545
Priority number, dateGB2004000359318.02.2004         Original published format: GB 0403593
GB2004001338616.06.2004         Original published format: GB 0413386
GB2004002303916.10.2004         Original published format: GB 0423039
[2006/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005080359
Date:01.09.2005
Language:EN
[2005/35]
Type: A1 Application with search report 
No.:EP1718624
Date:08.11.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 01.09.2005 takes the place of the publication of the European patent application.
[2006/45]
Type: B1 Patent specification 
No.:EP1718624
Date:25.03.2009
Language:EN
[2009/13]
Search report(s)International search report - published on:EP01.09.2005
ClassificationIPC:C07D277/46, C07D417/12, C07D231/40, C07D403/12, C07D487/08, A61K31/415, A61K31/426, A61K31/427, A61P3/10
[2006/45]
CPC:
C07D487/08 (EP,US); C07D277/46 (EP,KR,US); A61P3/00 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P43/00 (EP);
A61P5/10 (EP); A61P7/12 (EP); C07D231/40 (EP,US);
C07D403/12 (EP,US); C07D417/12 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/45]
Extension statesAL18.09.2006
BA18.09.2006
HR18.09.2006
LV18.09.2006
MK18.09.2006
YU18.09.2006
TitleGerman:BENZAMIDDERIVATE UND DEREN VERWENDUNG ALS GLUCOKINASEAKTIVIERENDE MITTEL[2006/45]
English:BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATING AGENTS[2006/45]
French:DERIVES DE BENZAMIDE ET LEUR UTILISATION EN TANT QU'ACTIVATEURS DE LA GLUCOKINASE[2006/45]
Entry into regional phase18.09.2006National basic fee paid 
18.09.2006Designation fee(s) paid 
18.09.2006Examination fee paid 
Examination procedure18.09.2006Examination requested  [2006/45]
05.04.2007Despatch of a communication from the examining division (Time limit: M06)
05.10.2007Reply to a communication from the examining division
20.03.2008Communication of intention to grant the patent
01.07.2008Fee for grant paid
01.07.2008Fee for publishing/printing paid
21.11.2008Despatch of a communication from the examining division (Time limit: M04)
05.12.2008Reply to a communication from the examining division
Divisional application(s)EP08158356.9  / EP2048137
Opposition(s)29.12.2009No opposition filed within time limit [2010/09]
Fees paidRenewal fee
28.02.2007Renewal fee patent year 03
29.02.2008Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.03.2009
BE25.03.2009
CY25.03.2009
CZ25.03.2009
DK25.03.2009
EE25.03.2009
FI25.03.2009
LT25.03.2009
PL25.03.2009
RO25.03.2009
SI25.03.2009
SK25.03.2009
BG25.06.2009
GR26.06.2009
IS25.07.2009
PT01.09.2009
HU26.09.2009
[2012/42]
Former [2012/37]AT25.03.2009
BE25.03.2009
CY25.03.2009
CZ25.03.2009
DK25.03.2009
EE25.03.2009
FI25.03.2009
LT25.03.2009
PL25.03.2009
RO25.03.2009
SI25.03.2009
SK25.03.2009
BG25.06.2009
GR26.06.2009
IS25.07.2009
PT01.09.2009
Former [2010/52]AT25.03.2009
BE25.03.2009
CZ25.03.2009
DK25.03.2009
EE25.03.2009
FI25.03.2009
LT25.03.2009
PL25.03.2009
RO25.03.2009
SI25.03.2009
SK25.03.2009
BG25.06.2009
GR26.06.2009
IS25.07.2009
PT01.09.2009
Former [2010/12]AT25.03.2009
BE25.03.2009
CZ25.03.2009
DK25.03.2009
EE25.03.2009
FI25.03.2009
LT25.03.2009
PL25.03.2009
RO25.03.2009
SI25.03.2009
SK25.03.2009
BG25.06.2009
IS25.07.2009
PT01.09.2009
Former [2009/52]AT25.03.2009
BE25.03.2009
CZ25.03.2009
EE25.03.2009
FI25.03.2009
LT25.03.2009
PL25.03.2009
RO25.03.2009
SI25.03.2009
SK25.03.2009
IS25.07.2009
PT01.09.2009
Former [2009/48]AT25.03.2009
BE25.03.2009
EE25.03.2009
FI25.03.2009
LT25.03.2009
PL25.03.2009
SI25.03.2009
Cited inInternational search[DY]WO03000267  (ASTRAZENECA AB [SE], et al) [DY] 1-17 * page 1 - page 2; example -; claim - *;
 [DY]WO03015774  (ASTRAZENECA AB [SE], et al) [DY] 1-17 * page 1 - page 2; example -; claim - *;
 [PY]WO2004076420  (BANYU PHARMA CO LTD [JP], et al) [PY] 1-17* example - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.